Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...
Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...
COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...
Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...
Concerns about COVID-19 have significantly diminished, but researchers continue to analyze its high transmission rate, aiming ...
Vaccination is gaining momentum after the initial supply concerns were sorted out. Kerala has achieved around 75% coverage of ...
In the article by Xie et al. (Aug. 8 issue) 1 regarding postacute sequelae of SARS-CoV-2 infection (PASC) in the pre-delta, delta, and omicron eras, the authors note that 71.89% of the decrease in ...
The health system will offer up to five weeks of back pay to staff that were denied religious exemptions for COVID-19 vaccine ...
KP.3 was the 'predominant' SARS-CoV-2 variant in the US. It was also spreading in Europe. It's now joined with another ...
Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...